Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
Harvard Scientists Discover How Cancer Outwits Erbitux Drug
Bloomberg
Thu, 09/8/11 - 11:15 am
Erbitux
Eli Lilly
breast cancer
Bristol-Myers Squibb
Peregrine Reports Promising 20.7 Month Median Overall Survival From Phase II Advanced Breast Cancer Trial
Yahoo
Wed, 08/24/11 - 09:23 am
Peregrine Pharmaceuticals
breast cancer
monoclonal antibodies
bavituximab
lung cancer
Roche CEO Schwan spotlights Roche's top three blockbuster hopefuls
Fierce Biotech
Mon, 08/22/11 - 01:16 pm
Roche
Severin Schwan
Metmab
lung cancer
lebrikizumab
Pertuzumab
asthma
breast cancer
Genentech pitches Avastin compromise to FDA
Fierce Pharma
Mon, 08/8/11 - 12:39 pm
FDA
breast cancer
Avastin
Genentech
Court Allows Patents On Breast Cancer Genes
Pharmalot
Mon, 08/1/11 - 10:28 am
genes
breast cancer
patents
Myriad Genetics
BRCA1
BRCA2
Roche's Cancer Drug Impresses
Yahoo/Zacks.com
Fri, 07/15/11 - 02:09 pm
Roche
GSK
Pertuzumab
breast cancer
Herceptin
Analyst says Immunogen's T-DM1 will become standard breast cancer treatment; rates stock 'Buy'
Yahoo/AP
Wed, 07/6/11 - 08:47 am
Immunogen
T-DM1
breast cancer
Novartis to File Drug for Breast Cancer
WSJ Online
Tue, 07/5/11 - 10:05 am
Novartis
breast cancer
Afinitor
Medicare Will Continue to Cover 2 Expensive Cancer Drugs
NY Times, NY
Fri, 07/1/11 - 09:55 am
Medicare
Provenge
prostate cancer
Dendreon
Roche
Avastin
breast cancer
What the Avastin Vote Means
Minyanville
Thu, 06/30/11 - 04:14 pm
Avastin
breast cancer
Roche
FDA
advisory panels
Federal panel says government should revoke cancer drug Avastin's approval for breast cancer
Yahoo/AP
Wed, 06/29/11 - 07:46 pm
Avastin
advisory panels
breast cancer
FDA
Roche
FDA Appeals Panel to Hold Avastin Hearing This Week
WSJ Online
Mon, 06/27/11 - 08:50 am
FDA
Avastin
Roche
breast cancer
Medicine's Next Revolution: 2 Cancer Vaccines With the Greatest Potential
Seeking Alpha
Sun, 06/26/11 - 12:03 pm
Dendreon
prostate cancer
DN24-02
Neuvenge
Provenge
Oncothyreon
Stimuvax
colorectal cancer
breast cancer
Keryx
Roche Won't Be Forced to Disclose Ties to Avastin Backers
San Francisco Gate, CA
Tue, 06/21/11 - 10:46 am
Roche
FDA
breast cancer
Avastin
APP launches generic version of Femara, drug linked to lower breast cancer risk in new study
Yahoo/AP
Tue, 06/7/11 - 06:15 pm
APP
Femara
breast cancer
generics
Novartis
Sanofi preps for new pivotal trial of a blockbuster hopeful
Fierce Biotech
Tue, 06/7/11 - 10:01 am
Sanofi
iniparib
breast cancer
Pfizer’s Aromasin Blocks Breast Cancer in Healthy, At-Risk Women in Study
Bloomberg
Sun, 06/5/11 - 10:32 am
Aromasin
Pfizer
breast cancer
NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
Sun, 06/5/11 - 10:24 am
NKTR-102
breast cancer
Nektar
topoisomerase I inhibitor
Filling an Unmet Need: A Look at Generex and RXI Pharma's Breast Cancer Vaccines
Seeking Alpha
Thu, 06/2/11 - 10:30 am
breast cancer
vaccines
Generex
RXi Pharmaceuticals
NeuVax
New breast cancer treatment: Researchers say it could help one-third of patients
Tue, 05/17/11 - 09:02 pm
breast cancer
cancer
research
Pages
« first
‹ previous
…
25
26
27
28
29
30
31
32
33
…
next ›
last »